These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23971928)

  • 1. [Seroepidemiology of pertussis in 10-15 years old healthy children in Isparta province, Turkey].
    Seçkin H; Ormeci AR; Sandal G; Kaya S
    Mikrobiyol Bul; 2013 Jul; 47(3):507-13. PubMed ID: 23971928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Seroprevalence of pertussis toxin antibody in Manisa province of Turkey, after six years implementation of acellular pertussis vaccine].
    Özbek ÖA; Öktem İMA; Hekimoğlu CH; Sekreter Ö; Emek M; Atasoylu G; Açıkgöz A; Demirpençe N; Ceylan A; Baykal ES; Ünal B
    Mikrobiyol Bul; 2018 Apr; 52(2):180-189. PubMed ID: 29933735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of seropositivity of Bordetella pertussis in adults in a university hospital].
    Öksüz L; Gürler N; Ağaçfidan A
    Mikrobiyol Bul; 2017 Jan; 51(1):62-72. PubMed ID: 28283011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of Bordetella pertussis specific Immunoglobulin G antibody levels among asymptomatic individuals aged 4 to 24 years: a descriptive cross sectional study from Sri Lanka.
    Sigera S; Perera J; Rasarathinam J; Samaranayake D; Ediriweera D
    BMC Infect Dis; 2016 Dec; 16(1):729. PubMed ID: 27905894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pertussis seroprevalence and vaccination status in three selected provinces of Turkey].
    Kurtoğlu D; Gözalan A; Cöplü N; Miyamura K; Ishida S; Morita M; Akin L; Esen B
    Mikrobiyol Bul; 2008 Jul; 42(3):389-98. PubMed ID: 18822881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transversal sero-epidemiological study of Bordetella pertussis in Tehran, Iran.
    Noel G; Badmasti F; Nikbin VS; Zahraei SM; Madec Y; Tavel D; Aït-Ahmed M; Guiso N; Shahcheraghi F; Taieb F
    PLoS One; 2020; 15(9):e0238398. PubMed ID: 32870922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
    Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
    Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia.
    Kurova N; Timofeeva EV; Guiso N; Macina D
    Vaccine; 2018 Dec; 36(52):7936-7942. PubMed ID: 30448334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
    Dalby T; Petersen JW; Harboe ZB; Krogfelt KA
    J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination.
    Wanlapakorn N; Ngaovithunvong V; Thongmee T; Vichaiwattana P; Vongpunsawad S; Poovorawan Y
    PLoS One; 2016; 11(2):e0148338. PubMed ID: 26837004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study.
    Zhang Q; Zheng H; Liu M; Han K; Shu J; Wu C; Xu N; He Q; Luo H
    BMC Infect Dis; 2012 Jun; 12():138. PubMed ID: 22892100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
    Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
    Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of high antibody titers of pertussis in Turkey: reflection of circulating microorganism and a threat to infants.
    Esen B; Coplu N; Kurtoglu D; Gozalan A; Akin L
    J Clin Lab Anal; 2007; 21(3):154-61. PubMed ID: 17506474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serological evaluation of Bordetella pertussis infection in adults with prolonged cough].
    Sönmez C; Çöplü N; Gözalan A; Yılmaz Ü; Bilekli S; Demirci NY; Biber Ç; Erdoğan Y; Esen B; Çöplü L
    Mikrobiyol Bul; 2016 Jul; 50(3):361-70. PubMed ID: 27525392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.
    Fry NK; Litt DJ; Duncan J; Vaghji L; Warrener L; Samuel D; Andrews N; Harnden A; Harrison TG
    J Med Microbiol; 2013 Sep; 62(Pt 9):1281-1289. PubMed ID: 23722435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroepidemiology of pertussis in Huzhou: A population-based, cross-sectional study.
    Liu Y; Zhang C; Wang Y; Luo X; Liu G; Zhang Z; Shen J
    PLoS One; 2024; 19(5):e0303508. PubMed ID: 38768133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of pertussis antibodies in 6-17-year-old students in Ahvaz, south-west Islamic Republic of Iran.
    Shamsizadeh A; Nikfar R; Yusefi H; Abbasi-Montazeri E; Cheraghian B
    East Mediterr Health J; 2014 Oct; 20(10):623-6. PubMed ID: 25356693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects.
    Subissi L; Rodeghiero C; Martini H; Litzroth A; Huygen K; Leroux-Roels G; Piérard D; Desombere I
    Clin Microbiol Infect; 2020 May; 26(5):645.e1-645.e8. PubMed ID: 31610300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of pertussis among adults in China where whole cell vaccines have been used for 50 years.
    Chen Z; Zhang J; Cao L; Zhang N; Zhu J; Ping G; Zhao J; Li S; He Q
    J Infect; 2016 Jul; 73(1):38-44. PubMed ID: 27063282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.